SW480细胞
文献支持

SW480细胞

收藏
  • ¥1320
  • BHcell(博辉生物)
  • BH-C131
  • 2025年12月04日
    avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    SW480/SW480细胞系/SW480细胞株/SW480人结肠腺癌细胞

    Cell line name SW480

    Synonyms SW-480; SW 480; SW480E

    Accession CVCL_0546

    Resource Identification Initiative To cite this cell line use: SW480 (RRID:CVCL_0546)

    Comments Part of: AstraZeneca Colorectal cell line (AZCL) panel.

    Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: KuDOS 95 cell line panel.

    Part of: MD Anderson Cell Lines Project.

    From: Scott and White Clinic; Temple; USA.

    Population: Caucasian.

    Doubling time: 50 hours (Note=At 73th passage) (PubMed=1000501); 30.74 hours (PubMed=25944804); 24 hours (PubMed=25984343); 20-25 hours (CLS=300302); ~25-30 hours (DSMZ=ACC-313); ~38 hours (PBCF).

    Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=10674020; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746).

    Omics: Deep exome analysis.

    Omics: Deep phosphoproteome analysis.

    Omics: Deep proteome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: Hi-C chromosome conformation analysis.

    Omics: miRNA expression profiling.

    Omics: N-glycan profiling.

    Omics: Nuclear proteome analysis.

    Omics: O-glycan profiling.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: shRNA library screening.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Misspelling: WE-480; Note=Occasionally.

    Misspelling: WE480; Note=Occasionally.

    Misspelling: SW80; Note=Occasionally.

    Misspelling: SWH80; BTO=BTO:0006552.

    Derived from site: In situ; Colon; UBERON=UBERON_0001155.

    PubMed=7651727

    Kastrinakis W.V., Ramchurren N., Rieger K.M., Hess D.T., Loda M., Steele G., Summerhayes I.C.

    Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.

    Oncogene 11:647-652(1995)

     

    PubMed=7824277

    Eshleman J.R., Lang E.Z., Bowerfind G.K., Parsons R., Vogelstein B., Willson J.K.V., Veigl M.L., Sedwick W.D., Markowitz S.D.

    Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer.

    Oncogene 10:33-37(1995)

     

    PubMed=8895552; DOI=10.1002/(SICI)1097-0215(19960927)68:1<126::AID-IJC22>3.0.CO;2-8

    Suardet L., Li C., Little J.B.

    Radio-induced modulation of transforming growth factor beta1 sensitivity in a p53 wild-type human colorectal-cancer cell line.

    Int. J. Cancer 68:126-131(1996)

     

    PubMed=9000147

    Cottu P.-H., Muzeau F., Estreicher A., Flejou J.-F., Iggo R.D., Thomas G., Hamelin R.

    Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines.

    Oncogene 13:2727-2730(1996)

     

    PubMed=9000572

    Hoang J.-M., Cottu P.-H., Thuille B., Salmon R.J., Thomas G., Hamelin R.

    BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.

    Cancer Res. 57:300-303(1997)

     

    PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D

    Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.

    Screening the p53 status of human cell lines using a yeast functional assay.

    Mol. Carcinog. 19:243-253(1997)

     

    PubMed=9294210; DOI=10.1073/pnas.94.19.10330; PMCID=PMC23362

    Ilyas M., Tomlinson I.P.M., Rowan A.J., Pignatelli M., Bodmer W.F.

    Beta-catenin mutations in cell lines established from human colorectal cancers.

    Proc. Natl. Acad. Sci. U.S.A. 94:10330-10334(1997)

     

    PubMed=9715273; DOI=10.1038/sj.onc.1201986

    Eshleman J.R., Casey G., Kochera M.E., Sedwick W.D., Swinler S.E., Veigl M.L., Willson J.K.V., Schwartz S., Markowitz S.D.

    Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53.

    Oncogene 17:719-725(1998)

     

    PubMed=10674020; DOI=10.1016/S0959-8049(99)00206-3

    Ku J.-L., Yoon K.-A., Kim D.-Y., Park J.-G.

    Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines.

    Eur. J. Cancer 35:1724-1729(1999)

     

    PubMed=10612807; DOI=10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; PMCID=PMC4721570

    Ghadimi B.M., Sackett D.L., Difilippantonio M.J., Schrock E., Neumann T., Jauho A., Auer G., Ried T.

    Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations.

    Genes Chromosomes Cancer 27:183-190(2000)

     

    PubMed=10737795; DOI=10.1073/pnas.97.7.3352; PMCID=PMC16243

    Rowan A.J., Lamlum H., Ilyas M., Wheeler J., Straub J., Papadopoulou A., Bicknell D.C., Bodmer W.F., Tomlinson I.P.M.

    APC mutations in sporadic colorectal tumors: a mutational 'hotspot' and interdependence of the 'two hits'.

    Proc. Natl. Acad. Sci. U.S.A. 97:3352-3357(2000)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由博辉生物科技(广州)有限公司提供; *发表【英文论文】请标注:From Bohui Biological Technology (Guangzhou) Co., Ltd.

    图标技术资料

    资料下载:

    SW480(BH-C131).docx 附 (下载 0 次)

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1400
    上海酶研生物科技有限公司
    2025年07月15日询价
    ¥900
    上海淳麦生物科技有限公司
    2025年07月14日询价
    ¥1400
    蒂科(上海)生物科技有限公司
    2025年11月03日询价
    ¥1680
    吉奥蓝图(广东)生命科学技术中心
    2025年09月25日询价
    ¥900
    上海泽叶生物科技有限公司
    2025年12月10日询价
    文献支持
    SW480细胞
    ¥1320